Evidence map›Paper›PMID 22035343›Full record

ArticleClinical genetics2012

Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency.

R Sebro, H Levy, K Schneck, D Dimmock, B A Raby, C L Cannon, U Broeckel, N J Risch

Abstract read
In one paragraph

Article in Clinical genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

R SebroInstitute for Human Genetics, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143, USA. ronnie.sebro@radiology.ucsf.edu
H Levy
K Schneck
D Dimmock
B A Raby
C L Cannon
U Broeckel
N J Risch
Brigham and Women's Hospital · USChildren's Hospital of Wisconsin · USClinical Research Institute · USKaiser Permanente Oakland Medical Center · USMedical College of Wisconsin · USPulmonary Associates · USThe University of Texas Southwestern Medical Center · USZero to Three · US

Funding

Integration of Genomics with Genetics - Molecular Phenotypes for CF Lung DiseaseDP2OD007031 · OD · MEDICAL COLLEGE OF WISCONSIN · PI LEVY, HARA · 2010 to 2010
$2.2M
Family Based Analysis of Modifiers of CF Lung DiseaseK23HL074202 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LEVY, HARA · 2003 to 2007
$617k
IL-1 Family Gene Polymorphisms and Susceptibility to P. aeruginosa in CF PatientsR21HL102523 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LEVY, HARA · 2010 to 2011
$413k
Howard Hughes Medical InstituteNHLBI NIH HHS K23 HL074202NHLBI NIH HHS R21 HL102523NIH HHS DP2 OD007031
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a monogenetic disease with a complex phenotype. Over 1500 mutations in the CFTR gene have been identified; however, the p.F508del mutation is most common. There has been limited correlation between the CFTR mutation genotype and the disease phenotypes. We evaluated the non-p.F508del mutation of 108 p.F508del compound heterozygotes using the biological classification method, Grantham and Sorting Intolerant from Tolerant (SIFT) scores to assess whether these scoring systems correlated with sweat chloride levels, pancreatic sufficiency, predicted FEV(1) , and risk of infection with Pseudomonas aeruginosa in the last year. Mutations predicted to be 'mild' by the biological classification method are associated with more normal sweat chloride levels (p < 0.001), pancreatic sufficiency (p < 0.001) and decreased risk of infection with Pseudomonas in the last year (p = 0.014). Lower Grantham scores are associated with more normal sweat chloride levels (p < 0.001), and pancreatic sufficiency (p = 0.014). Higher SIFT scores are associated with more normal sweat chloride levels (p < 0.001) and pancreatic sufficiency (p = 0.011). There was no association between pulmonary function measured by predicted FEV(1) and the biological classification (p = 0.98), Grantham (p = 0.28) or SIFT scores (p = 0.62), which suggests the pulmonary disease related to CF may involve other modifier genes and environmental factors.

Indexed as

HeterozygotePhenotypeChloridesCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGenotypeHumansLinear ModelsMassachusettsPancreasPseudomonas InfectionsRisk FactorsSequence DeletionSweatCFTR protein, humanChloridesCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID22035343
PMCPMC4279028
OpenAlexW2067521778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.